Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
V. Cabañas
Observed names:
Cabañas, Valentín,
Valentin Cabañas,
Valentín Cabañas
Institutions:
Instituto Murciano de Investigación Biosanitaria,
Hospital Universitario Virgen de la Arrixaca,
Universidad de Murcia
Observed institutions:
Instituto Murciano de Investigación Biosanitaria,
Hospital Universitario Virgen de la Arrixaca,
Universidad de Murcia
ORCID:
0000-0002-6248-2549
Observed ORCID:
0000-0002-6248-2549
OpenAlex ID:
A5011409875
Single-cell multiomics reveals regulatory mechanisms of CAR T-cell persistence and dysfunction in multiple myeloma
2026
·
Lorea Jordana-Urriza
, Guillermo Serrano
, et al.
·
Blood Neoplasia
·
6
Immune biomarkers of increased infection risk in multiple myeloma
2026
·
Aintzane Zabaleta
, Luis-Esteban Tamariz-Amador
, et al.
·
Blood
·
5
A critical analysis of the IMWG multiple myeloma complete response criterion in the era of mass spectrometry
2026
·
Noemí Puig
, Cristina Agulló
, et al.
·
HemaSphere
·
4
PDF
PA-044 Baseline Immune Fitness Defines a Transcriptional Subtype of Multiple Myeloma with Exceptional Response to Daratumumab-Based Regimens in the GEM2017FIT Trial
2026
·
Antonio Porlan Minarro
, Benat Ariceta Ganuza
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
OA-63 Refining Frailty Assessment in Transplant-Ineligible Multiple Myeloma: Geriatric Assessment in Hematology Enhances the Simplified Frailty Index for Benefit-Risk Evaluation of Quadruplet Therapy
2026
·
Borja Puertas
, Anna Sureda
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
OA-17 Discontinuation of Maintenance Therapy Guided by Minimal Residual Disease in Newly Diagnosed Multiple Myeloma: Long-Term Results of the GEM2014MAIN Study
2026
·
David F. Moreno
, Bruno Paiva
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Supplemental Table 7 from Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma [Dataset]
2025
·
Guerrero, Camila
, Larráyoz, María José
, et al.
·
DIGITAL.CSIC (Spanish National Research Council (CSIC))
P862: Serum Mass Spectrometry to Analyze Disease Response in Patients With Relapsed/refractory Multiple Myeloma Receiving Ari0002h, an Academic Bcma-directed Car T-cell Therapy
2022
·
I. Ortiz De Landazuri
, A. Oliver-Caldés
, et al.
·
HemaSphere
Show more works
View as search
Works count:
8
Citation count:
15
H-index:
3
I10-index:
Year
Topic
Type